Screener / SEC EDGAR /CIK 0001743881 /10-K filed Feb 24, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

BridgeBio Pharma, Inc. BBIO

Compare with peers Embed
Who owns BBIO

Institutional owners are on their way

13F data can be up to 45 days old

We read every 13F filing after each quarter ends. The owners of BBIO show here after the next update.

Institutional ownership

Institutional owners

13F data sets, SEC

Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of BBIO show here after the next update.

Funds that hold BBIO

Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.

Form N-PORT, SEC

Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold BBIO show here after the next update.

Superinvestors holding BBIO

Positions reported on Form 13F for the quarter ending Jun 30, 2026, and what each did since the quarter before. Width is the reported value.

All investors
Andreas Halvorsen: $741.0MPolen Capital: $298K Reduced: 2, $741.3M Andreas Halvorsen $741.0M · 2.1% of their portfolio Polen Capital $298K · 0.0% of their portfolio BBIO · 2 FOLLOWED INVESTORS $741.3M reported value, 13F REDUCED 2 investors · $741.3M
InvestorQuarterSharesValue% of portfolioLast quarter
Andreas Halvorsen Viking Global Investors Jun 30, 20269.95M$741.0M 2.11% Reduced -16.0%
Polen Capital Polen Capital Management Jun 30, 20264K$298K 0.00% Reduced -91.3%

13D filings: owners who may push for change

Owners of more than 5%

Schedule 13D, last year
Aug 17, 2026 13D/A 4.7%of BBIO's shares now below 5%
KKR Genetic Disorder L.P. and 8 more reporting persons · 9.23M shares · event Aug 13, 2026
Item 4, purpose of the transaction:Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Sale of Common Stock On August 13, 2026, KKR Genetic Disorder L.P., as a selling stockholder, and the Issuer entered into an underwriting agreement (the ''Underwriting Agreement'') with William Blair & Company, L.L.C., Goldman Sachs & Co. LLC and KKR Capital Markets LLC (the ''Representatives''), as the representatives of the several underwriters listed on Schedule I thereto (the ''Underwriters''), relating to an offering of 5,000,000 shares of Common Stock by KKR Genetic Disorder L.P. (the ''Offering''), and purchase by the Underwriters of the shares of Common Stock, at a net price to KKR Genetic Disorder L.P. of $7…
Read the filing
Jul 10, 2026 13D/A 5.0%of BBIO's shares ▼ down from 6.1% on Apr 2, 2026
Viking Global Investors LP and 6 more reporting persons · 9.79M shares · event Jul 9, 2026
Item 4, purpose of the transaction:Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 12 is incorporated by reference herein.
Read the filing
Apr 2, 2026 13D/A 6.1%of BBIO's shares ▼ down from 6.8% on Feb 17, 2026
Viking Global Investors LP and 6 more reporting persons · 11.84M shares · event Mar 31, 2026
Item 4, purpose of the transaction:Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 11 is incorporated by reference herein.
Read the filing
Feb 17, 2026 13D/A 6.8%of BBIO's shares ▼ down from 8.2% on Nov 14, 2025
Viking Global Investors LP and 7 more reporting persons · 13.03M shares · event Feb 12, 2026
Item 4, purpose of the transaction:Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 10 is incorporated by reference herein.
Read the filing

Sources

SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.

Also

Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.

Work with it

Excel workbook · CSV

Next:Cash & buybacks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.